Comment on

• Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

  Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Gomez Suescun JB, McGarry RC, Choy H, Bradley JD. Videtic GM, et al. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1077-1084. doi: 10.1016/j.ijrobp.2018.11.051. Epub 2018 Dec 1. Int J Radiat Oncol Biol Phys. 2019. PMID: 30513377 Free PMC article. Clinical Trial.
• Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

  Manyam BV, Videtic GMM, Verdecchia K, Reddy CA, Woody NM, Stephans KL. Manyam BV, et al. Pract Radiat Oncol. 2019 Mar;9(2):e187-e195. doi: 10.1016/j.prro.2018.11.011. Epub 2018 Dec 7. Pract Radiat Oncol. 2019. PMID: 30529796
• One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial.

  Singh AK, Gomez-Suescun JA, Stephans KL, Bogart JA, Hermann GM, Tian L, Groman A, Videtic GM. Singh AK, et al. Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):752-759. doi: 10.1016/j.ijrobp.2019.08.019. Epub 2019 Aug 22. Int J Radiat Oncol Biol Phys. 2019. PMID: 31445956 Free PMC article. Clinical Trial.